To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
PIPV Capital SPAC Ibere Pharmaceuticals goes public
Ibere Pharmaceuticals, a blank check company formed by PIPV Capital, has raised $120 million for its IPO after pricing its 12 million shares at $10 per share.
